Anti-retroviral drugs: current state and development in the next decade
The pace of discovery of new antiretroviral (ARV) drugs has slowed, although the efficacy and safety of once-daily fixed dose combinations have been extensively investigated. Several traditional ARV drugs remain in phase III clinical trials. This review summarizes current information on ARV drugs in...
Saved in:
Main Author: | Xingquan Zhang (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2018-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Measuring HIV-related mortality in the first decade of anti-retroviral therapy in sub-Saharan Africa
by: Jim Todd, et al.
Published: (2014) -
Contemporary Anti-Retroviral Drugs (ARVDs) Disrupt Follicular Development in Female Wistar Rats
by: Ohihoin AG, et al.
Published: (2023) -
The Effect of Anti-Tuberculosis Drugs on the Effectiveness of Anti-Retroviral Therapy in HIV-AIDS Patients
by: Hasriana Hasriana, et al.
Published: (2017) -
A Longitudinal Study on Adherence to Anti Retroviral Therapy and Its Determinants in Telangana State
by: Misha Gorantla, et al.
Published: (2019) -
Evidence-Based research in dentistry for the next decade
by: Francesco Chiappelli, et al.
Published: (2015)